Adenocarcinoma of the endometrium (also known as endometrial cancer or more broadly as uterine cancer or carcinoma of the uterine corpus) is the most common malignancy of the female genital tract in the United States. An estimated 49,560 new uterine cancer cases will occur in 2013, with 8190 deaths resulting from the disease. Uterine sarcomas (stromal/mesenchymal tumors) are uncommon malignancies, accounting for approximately 3% of all uterine cancers. The NCCN Guidelines for Uterine Neoplasms describe malignant epithelial carcinomas and uterine sarcomas; each of these major categories contains specific histologic groups that require different management. This excerpt of these guidelines focuses on early-stage disease.

  • 1.

    SiegelRNaishadhamDJemalA. Cancer statistics, 2013. CA Cancer J Clin2013;63:1130.

  • 2.

    D’AngeloEPratJ. Uterine sarcomas: a review. Gynecol Oncol2010;116:131139.

  • 3.

    Van den BoschTCoosemansAMorinaM. Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol2012;26:257266.

  • 4.

    KitchenerHCTrimbleEL. Endometrial cancer state of the science meeting. Int J Gynecol Cancer2009;19:134140.

  • 5.

    DinkelspielHEWrightJDLewinSNHerzogTJ. Contemporary clinical management of endometrial cancer. Obstet Gynecol Int2013;2013:583891.

  • 6.

    ObermairAYouldenDRYoungJP. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer2010;127:26782684.

    • Search Google Scholar
    • Export Citation
  • 7.

    KatzVL. Diagnostic procedures. Imaging, endometrial sampling, endoscopy: indications and contraindications, complications. In: KatzVLLentzGMLoboRAGershensonDM eds. Comprehensive Gynecology5th ed.Philadelphia, PA: Mosby; 2007:Chapter 11.

    • Search Google Scholar
    • Export Citation
  • 8.

    ResnickKEHampelHFishelRCohnDE. Current and emerging trends in Lynch syndrome identification in women with endometrial cancer. Gynecol Oncol2009;114:128134.

    • Search Google Scholar
    • Export Citation
  • 9.

    KwonJSScottJLGilksCB. Testing women with endometrial cancer to detect Lynch syndrome. J Clin Oncol2011;29:22472252.

  • 10.

    WinAKLindorNMWinshipI. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst2013;105:274279.

    • Search Google Scholar
    • Export Citation
  • 11.

    LancasterJMPowellCBKauffND. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol2007;107:159162.

    • Search Google Scholar
    • Export Citation
  • 12.

    MeyerLABroaddusRRLuKH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control2009;16:1422.

  • 13.

    BonnetDSelvesJToulasC. Simplified identification of Lynch syndrome: a prospective, multicenter study. Dig Liver Dis2012;44:515522.

  • 14.

    WalshCSBlumAWaltsA. Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening. Gynecol Oncol2010;116:516521.

    • Search Google Scholar
    • Export Citation
  • 15.

    ClarkeBACooperK. Identifying Lynch syndrome in patients with endometrial carcinoma: shortcomings of morphologic and clinical schemas. Adv Anat Pathol2012;19:231238.

    • Search Google Scholar
    • Export Citation
  • 16.

    Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med2009;11:3541.

    • Search Google Scholar
    • Export Citation
  • 17.

    SmithRACokkinidesVBrawleyOW. Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clinin press.

    • Search Google Scholar
    • Export Citation
  • 18.

    CrispensMA. Endometrial and ovarian cancer in lynch syndrome. Clin Colon Rectal Surg2012;25:97102.

  • 19.

    ManchandaRSaridoganEAbdelraheimA. Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS). Arch Gynecol Obstet2012;286:15551562.

    • Search Google Scholar
    • Export Citation
  • 20.

    JarvinenHJRenkonen-SinisaloLAktan-CollanK. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol2009;27:47934797.

    • Search Google Scholar
    • Export Citation
  • 21.

    SchmelerKMLynchHTChenLM. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med2006;354:261269.

    • Search Google Scholar
    • Export Citation
  • 22.

    CreasmanWTOdicinoFMaisonneuveP. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet2006;95(Suppl 1):S105143.

    • Search Google Scholar
    • Export Citation
  • 23.

    LajerHElnegaardSChristensenRD. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey. Acta Obstet Gynecol Scand2012;91:976982.

    • Search Google Scholar
    • Export Citation
  • 24.

    UedaSMKappDSCheungMK. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol2008;198:218 e211-216.

    • Search Google Scholar
    • Export Citation
  • 25.

    ChanJKShermanAEKappDS. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol2011;29:832838.

    • Search Google Scholar
    • Export Citation
  • 26.

    McCluggageWG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol2006;59:801812.

  • 27.

    McKenneyJKLongacreTA. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics. Adv Anat Pathol2009;16:122.

    • Search Google Scholar
    • Export Citation
  • 28.

    LeitaoMMJrKehoeSBarakatRR. Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol2009;113:105108.

    • Search Google Scholar
    • Export Citation
  • 29.

    GimpelsonRJRappoldHO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol1988;158:489492.

    • Search Google Scholar
    • Export Citation
  • 30.

    LeeJHDubinskyTAndreottiRF. ACR appropriateness Criteria pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q2011;27:139145.

    • Search Google Scholar
    • Export Citation
  • 31.

    OrtashiOJainSEmannuelO. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer. A prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol2008;137:232235.

    • Search Google Scholar
    • Export Citation
  • 32.

    CrivellaroCSignorelliMGuerraL. Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT. Gynecol Oncol2013;130:306311.

    • Search Google Scholar
    • Export Citation
  • 33.

    KitajimaKSuzukiKSendaM. Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?Ann Nucl Med2011;25:511519.

    • Search Google Scholar
    • Export Citation
  • 34.

    DukJMAaldersJGFleurenGJde BruijnHW. CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol1986;155:10971102.

  • 35.

    DukJMAaldersJGFleurenGJ. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Obstet Gynecol1989;73:661668.

    • Search Google Scholar
    • Export Citation
  • 36.

    PatsnerBOrrJWJrMannWJJr. Use of serum CA 125 measurement in posttreatment surveillance of early-stage endometrial carcinoma. Am J Obstet Gynecol1990;162:427429.

    • Search Google Scholar
    • Export Citation
  • 37.

    RosePGSommersRMRealeFR. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma. Obstet Gynecol1994;84:1216.

    • Search Google Scholar
    • Export Citation
  • 38.

    PriceFVChambersSKCarcangiuML. CA 125 may not reflect disease status in patients with uterine serous carcinoma. Cancer1998;82:17201725.

    • Search Google Scholar
    • Export Citation
  • 39.

    LeslieKKThielKWGoodheartMJ. Endometrial cancer. Obstet Gynecol Clin North Am2012;39:255268.

  • 40.

    SmithRABrooksDCokkinidesV. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening. CA Cancer J Clin2013;63:88105.

    • Search Google Scholar
    • Export Citation
  • 41.

    BoronowRCMorrowCPCreasmanWT. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol1984;63:825832.

    • Search Google Scholar
    • Export Citation
  • 42.

    CowlesTAMagrinaJFMastersonBJCapenCV. Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol1985;66:413416.

    • Search Google Scholar
    • Export Citation
  • 43.

    CreasmanWTMorrowCPBundyBN. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer1987;60:20352041.

    • Search Google Scholar
    • Export Citation
  • 44.

    BenedetJLBenderHJonesH. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet2000;70:209262.

    • Search Google Scholar
    • Export Citation
  • 45.

    WrightJDBarrena MedelNISehouliJ. Contemporary management of endometrial cancer. Lancet2012;379:13521360.

  • 46.

    EdgeSBByrdDRComptonCC. AJCC Cancer Staging Manual7th edition. New York, NY: Springer; 2010.

  • 47.

    PecorelliS. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet2009;105:103104.

  • 48.

    CreasmanW. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet2009;105:109.

  • 49.

    MarianiADowdySCPodratzKC. New surgical staging of endometrial cancer: 20 years later. Int J Gynaecol Obstet2009;105:110111.

  • 50.

    WethingtonSLBarrena MedelNIWrightJDHerzogTJ. Prognostic significance and treatment implications of positive peritoneal cytology in endometrial adenocarcinoma: unraveling a mystery. Gynecol Oncol2009;115:1825.

    • Search Google Scholar
    • Export Citation
  • 51.

    TakeshimaNNishidaHTabataT. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol2001;82:470473.

    • Search Google Scholar
    • Export Citation
  • 52.

    ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol2005;106:413425.

    • Search Google Scholar
    • Export Citation
  • 53.

    SolimanPTFrumovitzMSpannuthW. Lymphadenectomy during endometrial cancer staging: practice patterns among gynecologic oncologists. Gynecol Oncol2010;119:291294.

    • Search Google Scholar
    • Export Citation
  • 54.

    KumarSMarianiABakkum-GamezJN. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer. Gynecol Oncol2013;130:441445.

    • Search Google Scholar
    • Export Citation
  • 55.

    KilgoreLCPartridgeEEAlvarezRD. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol1995;56:2933.

    • Search Google Scholar
    • Export Citation
  • 56.

    HavrileskyLJCragunJMCalingaertB. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol2005;99:689695.

    • Search Google Scholar
    • Export Citation
  • 57.

    TodoYKatoHKaneuchiM. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet2010;375:11651172.

    • Search Google Scholar
    • Export Citation
  • 58.

    KitchenerHSwartAMQianQ. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet2009;373:125136.

    • Search Google Scholar
    • Export Citation
  • 59.

    Benedetti PaniciPBasileSManeschiF. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst2008;100:17071716.

    • Search Google Scholar
    • Export Citation
  • 60.

    SeamonLGFowlerJMCohnDE. Lymphadenectomy for endometrial cancer: the controversy. Gynecol Oncol2010;117:68.

  • 61.

    CreasmanWTMutchDEHerzogTJ. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid?Gynecol Oncol2010;116:293294.

  • 62.

    UccellaSPodratzKCAlettiGDMarianiA. Lymphadenectomy in endometrial cancer. Lancet2009;373:1170; author reply 1170-1171.

  • 63.

    UccellaSPodratzKCAlettiGDMarianiA. Re: systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst2009;101:897898; author reply 898-899.

    • Search Google Scholar
    • Export Citation
  • 64.

    MilamMRJavaJWalkerJL. Nodal metastasis risk in endometrioid endometrial cancer. Obstet Gynecol2012;119:286292.

  • 65.

    NeubauerNLLurainJR. The role of lymphadenectomy in surgical staging of endometrial cancer. Int J Surg Oncol2011;2011:814649.

  • 66.

    DanielAGPetersWA3rd. Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet Gynecol1988;71:612614.

    • Search Google Scholar
    • Export Citation
  • 67.

    GoffBARiceLW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol1990;38:4648.

  • 68.

    MarianiADowdySCClibyWA. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol2008;109:1118.

    • Search Google Scholar
    • Export Citation
  • 69.

    HirahatakeKHareyamaHSakuragiN. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol1997;65:8287.

    • Search Google Scholar
    • Export Citation
  • 70.

    FrederickPJStraughnJMJr. The role of comprehensive surgical staging in patients with endometrial cancer. Cancer Control2009;16:2329.

    • Search Google Scholar
    • Export Citation
  • 71.

    MoriKMNeubauerNL. Minimally invasive surgery in gynecologic oncology. ISRN Obstet Gynecol2013;2013:312982.

  • 72.

    MabroukMFrumovitzMGreerM. Trends in laparoscopic and robotic surgery among gynecologic oncologists: a survey update. Gynecol Oncol2009;112:501505.

    • Search Google Scholar
    • Export Citation
  • 73.

    WalkerJLPiedmonteMRSpirtosNM. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol2009;27:53315336.

    • Search Google Scholar
    • Export Citation
  • 74.

    WalkerJLPiedmonteMRSpirtosNM. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol2012;30:695700.

    • Search Google Scholar
    • Export Citation
  • 75.

    KingLPMillerDS. Recent progress: gynecologic oncology group trials in uterine corpus tumors. Rev Recent Clin Trials2009;4:7074.

  • 76.

    VergoteIAmantFNevenP. Is it safe to treat endometrial carcinoma endoscopically?J Clin Oncol2009;27:53055307.

  • 77.

    MouritsMJBijenCBArtsHJ. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol2010;11:763771.

    • Search Google Scholar
    • Export Citation
  • 78.

    ChoJEShamshirsazAHNezhatCNezhatF. New technologies for reproductive medicine: laparoscopy, endoscopy, robotic surgery and gynecology. A review of the literature. Minerva Ginecol2010;62:137167.

    • Search Google Scholar
    • Export Citation
  • 79.

    SeamonLGCohnDEHenrettaMS. Minimally invasive comprehensive surgical staging for endometrial cancer: robotics or laparoscopy?Gynecol Oncol2009;113:3641.

    • Search Google Scholar
    • Export Citation
  • 80.

    BoggessJFGehrigPACantrellL. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol2008;199:360 e361-369.

    • Search Google Scholar
    • Export Citation
  • 81.

    BanderaCAMagrinaJF. Robotic surgery in gynecologic oncology. Curr Opin Obstet Gynecol2009;21:2530.

  • 82.

    BellMCTorgersonJSeshadri-KreadenU. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. Gynecol Oncol2008;111:407411.

    • Search Google Scholar
    • Export Citation
  • 83.

    ElSahwiKSHooperCDe LeonMC. Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial cancer. Gynecol Oncol2012;124:260264.

    • Search Google Scholar
    • Export Citation
  • 84.

    SiestoGOrnaghiSIedaNVitobelloD. Robotic surgical staging for endometrial and cervical cancers in medically ill patients. Gynecol Oncol2013;129:593597.

    • Search Google Scholar
    • Export Citation
  • 85.

    JerniganAMAuerMFaderANEscobarPF. Minimally invasive surgery in gynecologic oncology: a review of modalities and the literature. Womens Health (Lond Engl)2012;8:239250.

    • Search Google Scholar
    • Export Citation
  • 86.

    van DamPHauspyJVerkinderenL. Are costs of robot-assisted surgery warranted for gynecological procedures?Obstet Gynecol Int2011;2011:973830.

    • Search Google Scholar
    • Export Citation
  • 87.

    BrudieLABackesFJAhmadS. Analysis of disease recurrence and survival for women with uterine malignancies undergoing robotic surgery. Gynecol Oncol2013;128:309315.

    • Search Google Scholar
    • Export Citation
  • 88.

    BackesFJBrudieLAFarrellMR. Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecol Oncol2012;125:546551.

    • Search Google Scholar
    • Export Citation
  • 89.

    FlemingNDRamirezPT. Robotic surgery in gynecologic oncology. Curr Opin Oncol2012;24:547553.

  • 90.

    WeinbergLRaoSEscobarPF. Robotic surgery in gynecology: an updated systematic review. Obstet Gynecol Int2011;2011:852061.

  • 91.

    KrillLSBristowRE. Robotic surgery: gynecologic oncology. Cancer J2013;19:167176.

  • 92.

    RamirezPTAdamsSBoggessJF. Robotic-assisted surgery in gynecologic oncology: a Society of Gynecologic Oncology consensus statement. Developed by the Society of Gynecologic Oncology’s Clinical Practice Robotics Task Force. Gynecol Oncol2012;124:180184.

    • Search Google Scholar
    • Export Citation
  • 93.

    ManfrediRMirkPMarescaG. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology2004;231:372378.

    • Search Google Scholar
    • Export Citation
  • 94.

    AkinOMironovSPandit-TaskarNHannLE. Imaging of uterine cancer. Radiol Clin North Am2007;45:167182.

  • 95.

    GundersonCCFaderANCarsonKABristowRE. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol2012;125:477482.

    • Search Google Scholar
    • Export Citation
  • 96.

    BakerJObermairAGebskiVJandaM. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol2012;125:263270.

    • Search Google Scholar
    • Export Citation
  • 97.

    GraciaCRJerussJS. Lives in the balance: women with cancer and the right to fertility care. J Clin Oncol2013;31:668669.

  • 98.

    UshijimaKYahataHYoshikawaH. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol2007;25:27982803.

    • Search Google Scholar
    • Export Citation
  • 99.

    TrimbleCLMethodMLeitaoM. Management of endometrial precancers. Obstet Gynecol2012;120:11601175.

  • 100.

    MehassebMKLatimerJA. Controversies in the management of endometrial carcinoma: an update. Obstet Gynecol Int2012;2012:676032.

  • 101.

    HahnHSYoonSGHongJS. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer2009;19:10681073.

    • Search Google Scholar
    • Export Citation
  • 102.

    ParkJYKimDYKimJH. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002). Eur J Cancer2013;49:868874.

    • Search Google Scholar
    • Export Citation
  • 103.

    ParkJYSeongSJKimTJ. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer. Obstet Gynecol2013;121:136142.

    • Search Google Scholar
    • Export Citation
  • 104.

    WrightJDBuckAMShahM. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol2009;27:12141219.

  • 105.

    KoskasMBendifallahSLutonD. Safety of uterine and/or ovarian preservation in young women with grade 1 intramucous endometrial adenocarcinoma: a comparison of survival according to the extent of surgery. Fertil Steril2012;98:12291235.

    • Search Google Scholar
    • Export Citation
  • 106.

    LeeTSLeeJYKimJW. Outcomes of ovarian preservation in a cohort of premenopausal women with early-stage endometrial cancer: a Korean Gynecologic Oncology Group study. Gynecol Oncol2013;131:289293.

    • Search Google Scholar
    • Export Citation
  • 107.

    FishmanDARobertsKBChambersJT. Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium. Gynecol Oncol1996;61:189196.

    • Search Google Scholar
    • Export Citation
  • 108.

    CoonDBeriwalSHeronDE. High-dose-rate Rotte “Y” applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results. Int J Radiat Oncol Biol Phys2008;71:779783.

    • Search Google Scholar
    • Export Citation
  • 109.

    NiaziTMSouhamiLPortelanceL. Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I-II endometrial carcinoma. Int J Radiat Oncol Biol Phys2005;63:11081113.

    • Search Google Scholar
    • Export Citation
  • 110.

    GadducciACosioSGenazzaniAR. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: hormonal therapy, chemotherapy and molecularly targeted therapies. Crit Rev Oncol Hematol2006;58:242256.

    • Search Google Scholar
    • Export Citation
  • 111.

    MountziosGPectasidesDBournakisE. Developments in the systemic treatment of endometrial cancer. Crit Rev Oncol Hematol2011;79:278292.

    • Search Google Scholar
    • Export Citation
  • 112.

    FioricaJVBrunettoVLHanjaniP. Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2004;92:1014.

    • Search Google Scholar
    • Export Citation
  • 113.

    AltmanADThompsonJNelsonG. Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study. J Obstet Gynaecol Can2012;34:664672.

    • Search Google Scholar
    • Export Citation
  • 114.

    BarkerLCBrandIRCrawfordSM. Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma. Curr Med Res Opin2009;25:11051109.

    • Search Google Scholar
    • Export Citation
  • 115.

    RosePGBrunettoVLVanLeL. A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2000;78:212216.

    • Search Google Scholar
    • Export Citation
  • 116.

    DecruzeSBGreenJA. Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. Int J Gynecol Cancer2007;17:964978.

    • Search Google Scholar
    • Export Citation
  • 117.

    MorrowCPBundyBNKurmanRJ. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol1991;40:5565.

    • Search Google Scholar
    • Export Citation
  • 118.

    CreutzbergCLNoutRA. The role of radiotherapy in endometrial cancer: current evidence and trends. Curr Oncol Rep2011;13:472478.

  • 119.

    NeubauerNLHavrileskyLJCalingaertB. The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Gynecol Oncol2009;112:511516.

    • Search Google Scholar
    • Export Citation
  • 120.

    GretzHFrEconomosKHusainA. The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma. Gynecol Oncol1996;61:409415.

    • Search Google Scholar
    • Export Citation
  • 121.

    Ben-ShacharIPavelkaJCohnDE. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol2005;105:487493.

    • Search Google Scholar
    • Export Citation
  • 122.

    CreutzbergCLvan PuttenWLKoperPC. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet2000;355:14041411.

    • Search Google Scholar
    • Export Citation
  • 123.

    AaldersJAbelerVKolstadPOnsrudM. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol1980;56:419427.

    • Search Google Scholar
    • Export Citation
  • 124.

    BlakePSwartAMOrtonJ. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet2009;373:137146.

    • Search Google Scholar
    • Export Citation
  • 125.

    KeysHMRobertsJABrunettoVL. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol2004;92:744751.

    • Search Google Scholar
    • Export Citation
  • 126.

    CreutzbergCLvan PuttenWLJWárlám-RodenhuisCC. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol2004;22:12341241.

    • Search Google Scholar
    • Export Citation
  • 127.

    ScholtenANvan PuttenWLJBeermanH. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys2005;63:834838.

    • Search Google Scholar
    • Export Citation
  • 128.

    HockelMDornhoferN. Treatment of early endometrial carcinoma: is less more?Lancet2009;373:9799.

  • 129.

    CreutzbergCLNoutRALybeertML. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys2011;81:e631638.

    • Search Google Scholar
    • Export Citation
  • 130.

    AlektiarKMVenkatramanEChiDSBarakatRR. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncol Biol Phys2005;62:111117.

    • Search Google Scholar
    • Export Citation
  • 131.

    NoutRASmitVTPutterH. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet2010;375:816823.

    • Search Google Scholar
    • Export Citation
  • 132.

    SmallWJrBeriwalSDemanesDJ. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy2012;11:5867.

    • Search Google Scholar
    • Export Citation
  • 133.

    OnsrudMCvancarovaMHellebustTP. Long-term outcomes after pelvic radiation for early-stage endometrial cancer. J Clin Oncol2013;31:39513956.

    • Search Google Scholar
    • Export Citation
  • 134.

    NoutRAPutterHJurgenliemk-SchulzIM. Five-year quality of life of endometrial cancer patients treated in the randomised Post Operative Radiation Therapy in Endometrial Cancer (PORTEC-2) trial and comparison with norm data. Eur J Cancer2012;48:16381648.

    • Search Google Scholar
    • Export Citation
  • 135.

    RoperBAstnerSTHeydemann-ObradovicA. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients. Gynecol Oncol2007;107:541548.

    • Search Google Scholar
    • Export Citation
  • 136.

    NoutRAPutterHJurgenliemk-SchulzIM. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol2009;27:35473556.

    • Search Google Scholar
    • Export Citation
  • 137.

    McCloskeySATchaboNEMalhotraHK. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecol Oncol2010;116:404407.

    • Search Google Scholar
    • Export Citation
  • 138.

    ChinoJPJonesEBerchuckA. The Influence of Radiation Modality and Lymph Node Dissection on Survival in Early-stage Endometrial Cancer. Int J Radiat Oncol Biol Phys2012;82:18721879.

    • Search Google Scholar
    • Export Citation
  • 139.

    LeeCMSzaboAShrieveDC. Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma. JAMA2006;295:389397.

    • Search Google Scholar
    • Export Citation
  • 140.

    JohnsonNCornesP. Survival and recurrent disease after postoperative radiotherapy for early endometrial cancer: systematic review and meta-analysis. BJOG2007;114:13131320.

    • Search Google Scholar
    • Export Citation
  • 141.

    KongAJohnsonNCornesP. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev2007:CD003916.

  • 142.

    KongAJohnsonNKitchenerHCLawrieTA. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst2012;104:16251634.

    • Search Google Scholar
    • Export Citation
  • 143.

    EifelPJ. The role of adjuvant radiation therapy for stage I endometrial cancer: does meta-analysis reveal the answer?J Natl Cancer Inst2012;104:16151616.

    • Search Google Scholar
    • Export Citation
  • 144.

    HogbergTSignorelliMde OliveiraCF. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer—results from two randomised studies. Eur J Cancer2010;46:24222431.

    • Search Google Scholar
    • Export Citation
  • 145.

    JohnsonNBryantAMilesT. Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev2011:CD003175.

  • 146.

    LeTMenardCSamantR. Longitudinal assessments of quality of life in endometrial cancer patients: effect of surgical approach and adjuvant radiotherapy. Int J Radiat Oncol Biol Phys2009;75:795802.

    • Search Google Scholar
    • Export Citation
  • 147.

    SalaniRBackesFJFungMF. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol2011;204:466478.

    • Search Google Scholar
    • Export Citation
  • 148.

    Fung-Kee-FungMDodgeJElitL. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol2006;101:520529.

    • Search Google Scholar
    • Export Citation
  • 149.

    GreerBEGoffBAKohWJ. Endometrial carcinoma. In: JohnsonFEVirgoKS eds. Cancer Patient Follow-up. St. Louis: Mosby; 1997:357377.

  • 150.

    BristowREPurintonSCSantillanA. Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol2006;103:709713.

    • Search Google Scholar
    • Export Citation
  • 151.

    Cowens-AlvaradoRSharpeKPratt-ChapmanM. Advancing survivorship care through the National Cancer Survivorship Resource Center: developing American Cancer Society guidelines for primary care providers. CA Cancer J Clin2013;63:147150.

    • Search Google Scholar
    • Export Citation
  • 152.

    McCabeMSBhatiaSOeffingerKC. American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol2013;31:631640.

    • Search Google Scholar
    • Export Citation
  • 153.

    SmithWANolanVGRobisonLL. Physical activity among cancer survivors and those with no history of cancer—a report from the National Health and Nutrition Examination Survey 2003-2006. Am J Transl Res2011;3:342350.

    • Search Google Scholar
    • Export Citation
  • 154.

    CooperALDornfeld-FinkeJMBanksHW. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?Obstet Gynecol2006;107:7176.

    • Search Google Scholar
    • Export Citation
  • 155.

    SalaniRNagelCIDrennenEBristowRE. Recurrence patterns and surveillance for patients with early stage endometrial cancer. Gynecol Oncol2011;123:205207.

    • Search Google Scholar
    • Export Citation
  • 156.

    SmithDCPrenticeRThompsonDJHerrmannWL. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med1975;293:11641167.

  • 157.

    ZielHKFinkleWD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med1975;293:11671170.

  • 158.

    CreasmanWTHendersonDHinshawWClarke-PearsonDL. Estrogen replacement therapy in the patient treated for endometrial cancer. Obstet Gynecol1986;67:326330.

    • Search Google Scholar
    • Export Citation
  • 159.

    LeeRBBurkeTWParkRC. Estrogen replacement therapy following treatment for stage I endometrial carcinoma. Gynecol Oncol1990;36:189191.

    • Search Google Scholar
    • Export Citation
  • 160.

    ChapmanJADiSaiaPJOsannK. Estrogen replacement in surgical stage I and II endometrial cancer survivors. Am J Obstet Gynecol1996;175:11951200.

    • Search Google Scholar
    • Export Citation
  • 161.

    BarakatRRBundyBNSpirtosNM. Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study. J Clin Oncol2006;24:587592.

    • Search Google Scholar
    • Export Citation
  • 162.

    ChlebowskiRTHendrixSLLangerRD. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA2003;289:32433253.

    • Search Google Scholar
    • Export Citation
  • 163.

    AndersonGLLimacherMAssafAR. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA2004;291:17011712.

    • Search Google Scholar
    • Export Citation
  • 164.

    LaCroixAZChlebowskiRTMansonJE. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA2011;305:13051314.

    • Search Google Scholar
    • Export Citation
  • 165.

    PachmanDRJonesJMLoprinziCL. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. Int J Womens Health2010;2:123135.

    • Search Google Scholar
    • Export Citation
  • 166.

    MorrowPKMattairDNHortobagyiGN. Hot flashes: a review of pathophysiology and treatment modalities. Oncologist2011;16:16581664.

  • 167.

    LevineJP. Treating menopausal symptoms with a tissue-selective estrogen complex. Gend Med2011;8:5768.

  • 168.

    PinkertonJVUtianWHConstantineGD. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial. Menopause2009;16:11161124.

    • Search Google Scholar
    • Export Citation
  • 169.

    LoprinziCLBartonDLQinR. Nonestrogenic management of hot flashes. J Clin Oncol2011;29:38423846.

  • 170.

    SiderasKLoprinziCL. Nonhormonal management of hot flashes for women on risk reduction therapy. J Natl Compr Canc Netw2010;8:11711179.

    • Search Google Scholar
    • Export Citation
  • 171.

    CastellsMCTennantNMSloaneDE. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol2008;122:574580.

    • Search Google Scholar
    • Export Citation
  • 172.

    DizonDSSabbatiniPJAghajanianC. Analysis of patients with epithelial ovarian cancer or fallopian tube carcinoma retreated with cisplatin after the development of a carboplatin allergy. Gynecol Oncol2002;84:378382.

    • Search Google Scholar
    • Export Citation
  • 173.

    SampsonHAMunoz-FurlongACampbellRL. Second symposium on the definition and management of anaphylaxis: summary report—second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med2006;47:373380.

    • Search Google Scholar
    • Export Citation
  • 174.

    ManivannanVDeckerWWSteadLG. Visual representation of National Institute of Allergy and Infectious Disease and Food Allergy and Anaphylaxis Network criteria for anaphylaxis. Int J Emerg Med2009;2:35.

    • Search Google Scholar
    • Export Citation
  • 175.

    LenzHJ. Management and preparedness for infusion and hypersensitivity reactions. Oncologist2007;12:601609.

  • 176.

    MarkmanMZanottiKPetersonG. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity. J Clin Oncol2003;21:46114614.

    • Search Google Scholar
    • Export Citation
  • 177.

    LeeCWMatulonisUACastellsMC. Rapid inpatient/outpatient desensitization for chemotherapy hypersensitivity: standard protocol effective in 57 patients for 255 courses. Gynecol Oncol2005;99:393399.

    • Search Google Scholar
    • Export Citation
  • 178.

    LeeCWMatulonisUACastellsMC. Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions. Gynecol Oncol2004;95:370376.

    • Search Google Scholar
    • Export Citation
  • 179.

    MarkmanMHsiehFZanottiK. Initial experience with a novel desensitization strategy for carboplatin-associated hypersensitivity reactions: carboplatin-hypersensitivity reactions. J Cancer Res Clin Oncol2004;130:2528.

    • Search Google Scholar
    • Export Citation
  • 180.

    BorutaDM2ndGehrigPAFaderANOlawaiyeAB. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol2009;115:142153.

    • Search Google Scholar
    • Export Citation
  • 181.

    OlawaiyeABBorutaDM2nd. Management of women with clear cell endometrial cancer: a Society of Gynecologic Oncology (SGO) review. Gynecol Oncol2009;113:277283.

    • Search Google Scholar
    • Export Citation
  • 182.

    MendivilASchulerKMGehrigPA. Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control2009;16:4652.

    • Search Google Scholar
    • Export Citation
  • 183.

    VarugheseJHuiPLuL. Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression. J Oncol2011;2011:628084.

    • Search Google Scholar
    • Export Citation
  • 184.

    KernochanLEGarciaRL. Carcinosarcomas (malignant mixed Mullerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics. J Natl Compr Canc Netw2009;7:550556; quiz 557.

    • Search Google Scholar
    • Export Citation
  • 185.

    CirisanoFDJrRobboySJDodgeRK. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol2000;77:5565.

    • Search Google Scholar
    • Export Citation
  • 186.

    HendricksonMRLongacreTAKempsonRL. Uterine papillary serous carcinoma revisited. Gynecol Oncol1994;54:261263.

  • 187.

    McCluggageWG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer2002;12:687690.

    • Search Google Scholar
    • Export Citation
  • 188.

    CantrellLAHavrileskyLMooreDT. A multiinstitutional cohort study of adjuvant therapy in stage I-II uterine carcinosarcoma. Gynecol Oncol2012;127:2226.

    • Search Google Scholar
    • Export Citation
  • 189.

    KanthanRSengerJL. Uterine carcinosarcomas (malignant mixed mullerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int2011;2011:470795.

    • Search Google Scholar
    • Export Citation
  • 190.

    D’AngeloEPratJ. Pathology of mixed Mullerian tumours. Best Pract Res Clin Obstet Gynaecol2011;25:705718.

  • 191.

    de JongRANijmanHWWijbrandiTF. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component. Mod Pathol2011;24:13681379.

    • Search Google Scholar
    • Export Citation
  • 192.

    VorgiasGFotiouS. The role of lymphadenectomy in uterine carcinosarcomas (malignant mixed mullerian tumours): a critical literature review. Arch Gynecol Obstet2010;282:659664.

    • Search Google Scholar
    • Export Citation
  • 193.

    FaderANDrakeRDO’MalleyDM. Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. Cancer2009;115:21192127.

    • Search Google Scholar
    • Export Citation
  • 194.

    FaderANNagelCAxtellAE. Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. Gynecol Oncol2009;112:558562.

    • Search Google Scholar
    • Export Citation
  • 195.

    VandenputITrovikJVergoteI. The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium: a collaborative study. Int J Gynecol Cancer2011;21:332336.

    • Search Google Scholar
    • Export Citation
  • 196.

    KellyMGO’MalleyD MHuiP. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol2005;98:353359.

    • Search Google Scholar
    • Export Citation
  • 197.

    ThomasMBMarianiAClibyWA. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol2007;107:186189.

    • Search Google Scholar
    • Export Citation
  • 198.

    GoldbergHMillerRCAbdah-BortnyakR. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN). Gynecol Oncol2008;108:298305.

    • Search Google Scholar
    • Export Citation
  • 199.

    HamiltonCACheungMKOsannK. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol2006;103:679683.

    • Search Google Scholar
    • Export Citation
  • 200.

    GriceJEkMGreerB. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol1998;69:6973.

    • Search Google Scholar
    • Export Citation
  • 201.

    HavrileskyLJSecordAABae-JumpV. Outcomes in surgical stage I uterine papillary serous carcinoma. Gynecol Oncol2007;105:677682.

  • 202.

    SuttonGAxelrodJHBundyBN. Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group. Gynecol Oncol2006;100:349354.

    • Search Google Scholar
    • Export Citation
  • 203.

    FaderANBorutaDOlawaiyeABGehrigPA. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol2010;22:2129.

    • Search Google Scholar
    • Export Citation
  • 204.

    HomesleyHDFiliaciVMarkmanM. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol2007;25:526531.

    • Search Google Scholar
    • Export Citation
  • 205.

    EinsteinMHFrimerMKuoDY. Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma. Gynecol Oncol2012;124:2125.

    • Search Google Scholar
    • Export Citation
  • 206.

    RandallMEFiliaciVLMussH. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol2006;24:3644.

    • Search Google Scholar
    • Export Citation
  • 207.

    GalaalKvan der HeijdenEGodfreyK. Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma. Cochrane Database Syst Rev2013;2:CD006812.

    • Search Google Scholar
    • Export Citation
  • 208.

    WangWDoVHoggR. Uterine papillary serous carcinoma: patterns of failure and survival. Aust N Z J Obstet Gynaecol2009;49:419425.

  • 209.

    MehtaNYamadaSDRotmenschJMundtAJ. Outcome and pattern of failure in pathologic stage I-II papillary serous carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys2003;57:10041009.

    • Search Google Scholar
    • Export Citation
  • 210.

    MurphyKTRotmenschJYamadaSDMundtAJ. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys2003;55:12721276.

    • Search Google Scholar
    • Export Citation
  • 211.

    SoodBMJonesJGuptaS. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys2003;57:208216.

    • Search Google Scholar
    • Export Citation
  • 212.

    WolfsonAHBradyMFRoceretoT. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol2007;107:177185.

    • Search Google Scholar
    • Export Citation
  • 213.

    SuttonGBrunettoVLKilgoreL. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study. Gynecol Oncol2000;79:147153.

    • Search Google Scholar
    • Export Citation
  • 214.

    HensleyML. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas. Best Pract Res Clin Obstet Gynaecol2011;25:773782.

    • Search Google Scholar
    • Export Citation
  • 215.

    SuttonGKaudererJCarsonLF. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study. Gynecol Oncol2005;96:630634.

    • Search Google Scholar
    • Export Citation
  • 216.

    PowellMAFiliaciVLRosePG. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. J Clin Oncol2010;28:27272731.

    • Search Google Scholar
    • Export Citation
  • 217.

    ReedNSMangioniCMalmströmH. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer2008;44:808818.

    • Search Google Scholar
    • Export Citation
  • 218.

    CallisterMRamondettaLMJhingranA. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys2004;58:786796.

    • Search Google Scholar
    • Export Citation
  • 219.

    ChiDSMychalczakBSaigoPE. The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma. Gynecol Oncol1997;65:493498.

    • Search Google Scholar
    • Export Citation
  • 220.

    KnockeTHWeitmannHDKuceraH. Results of primary and adjuvant radiotherapy in the treatment of mixed Müllerian tumors of the corpus uteri. Gynecol Oncol1999;73:389395.

    • Search Google Scholar
    • Export Citation
  • 221.

    LarsonBSilfverswärdCNilssonBPetterssonF. Mixed müllerian tumours of the uterus—prognostic factors: a clinical and histopathologic study of 147 cases. Radiother Oncol1990;17:123132.

    • Search Google Scholar
    • Export Citation
  • 222.

    GersztenKFaulCKounelisS. The impact of adjuvant radiotherapy on carcinosarcoma of the uterus. Gynecol Oncol1998;68:813.

  • 223.

    DusenberyKEPotishRAArgentaPAJudsonPL. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus. Am J Clin Oncol2005;28:295300.

    • Search Google Scholar
    • Export Citation
  • 224.

    NemaniDMitraNGuoMLinL. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol2008;111:8288.

    • Search Google Scholar
    • Export Citation
  • 225.

    LeeCHMarino-EnriquezAOuW. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor. Am J Surg Pathol2012;36:641653.

    • Search Google Scholar
    • Export Citation
  • 226.

    LeeCHOuWBMarino-EnriquezA. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma. Proc Natl Acad Sci U S A2012;109:929934.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 196 196 27
PDF Downloads 37 37 2
EPUB Downloads 0 0 0